References
- LawSLHuangKJChiangCHAcyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorptionJ Control Release2000631–213514010640587
- MeisnerDMezeiMLiposome ocular delivery systemsAdv Drug Deliv Rev19811617593
- MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
- JoresKMehnertWDrechslerMBunjesHJohannCMäderKInvestigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopyJ Control Release200495221722714980770
- MehnertWMäderKSolid lipid nanoparticles: production, characterization and applicationsAdv Drug Deliv Rev2001472–316519611311991
- AttamaAAReichlSMüller-GoymannCCDiclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea constructInt J Pharm20083551–230731318242022
- Müller-GoymannCCPhysicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administrationEur J Pharm Biopharm200458234335615296960
- PardeikeJHommossAMüllerRHLipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal productsInt J Pharm20093661–217018418992314
- JenningVThünemannAFGohlaSHCharacterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipidsInt J Pharm2000199216717710802410
- AttamaAASchickeBCMüller-GoymannCCFurther characterization of theobroma oil-beeswax admixtures as lipid matrices for improved drug delivery systemsEur J Pharm Biopharm200664329430616949805
- WissingSAKayserOMüllerRHSolid lipid nanoparticles for parenteral drug deliveryAdv Drug Deliv Rev20045691257127215109768
- FriedlaenderMHTakruriHRiolan Tehcnologies, IncCompositions, methods, and kits for treating dry eyeUnited States Patent 200702590211182007
- MarenTHHaywoodJRChapmanSKZimmermanTJThe pharmacology of methazolamide in relation to the treatment of glaucomaInvest Ophthalmol Vis Sci1977168730742407172
- EdelhauserHFMarenTHPermeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitorsArch Ophthalmol19881068111011153401140
- FridriksdóttirHLoftssonTStefánssonEFormulation and testing of methazolamide cyclodextrin eye drop solutionsJ Control Release19974419599
- ChenRQianYLiRMethazolamide calcium phosphate nanoparticles in an ocular delivery systemYakugaku Zasshi2010130341942420190526
- QianYWangFLiRZhangQXuQPreparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamideDrug Dev Ind Pharm201036111340134720849349
- LiRJiangSLiuDA potential new therapeutic system for glaucoma: solid lipid nanoparticles containing methazolamideJ Microencapsul201128213414121142697
- KaurIPGargASinglaAKAggarwalDVesicular systems in ocular drug delivery: an overviewInt J Pharm2004269111414698571
- HouDXieCHuangKZhuCThe production and characteristics of solid lipid nanoparticles (SLNs)Biomaterials200324101781178512593960
- NasrMMansourSMortadaNDEl ShamyAALipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluationAAPS Pharm Sci Tech200891154162
- HathoutRMMansourSMortadaNDGuinediASLiposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studiesAAPS Pharm Sci Tech2007811
- WinumJYCasiniAMincioneFCarbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbitsBioorg Med Chem Lett200414122522914684332
- MonemASAliFMIsmailMWProlonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbitsInt J Pharm20001981293810722948
- HazletonLWRelation of surface-active properties of irritation of the rabbit eyeProc Sci Sect T G A19521718
- KlangSFrucht-PeryJHoffmanABenitaSPhysicochemical characterization and acute toxicity evaluation of a positively-charged submicron emulsion vehicleJ Pharm Pharmacol199446129869937714723
- AttamaAASchickeBCPaepenmüllerTMüller-GoymannCCSolid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterizationEur J Pharm Biopharm2007671485717276663
- SannaVCariaGMarianiAEffect of lipid nanoparticles containing fatty alcohols having different chain length on the ex vivo skin permeability of econazole nitratePowder Technology201020113236
- VarshosazJTabbakhianMMohammadiMYFormulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailabilityJ Liposome Res201020428629619958118
- VarshosazJMinayianMMoazenEEnhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticlesJ Liposome Res201020211512319694503
- ZimmerAKreuterJMicrospheres and nanoparticles used in ocular delivery systemsAdv Drug Deliv Rev1995166173
- Gonzalez-MiraEEgeaMAGarciaMLSoutoEBDesign and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLCColloids Surf B Biointerfaces201081241242120719479
- SchubertMAMüller-GoymannCCCharacterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifierEur J Pharm Biopharm2005611–2778616011893
- AttamaAAMüller-GoymannCCInvestigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipidInt J Pharm20073341–217918917140752
- KheradmandniaSVasheghani-FarahaniENosratiMAtyabiFPreparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba waxNanomedicine20106675375920599527
- zur MühlenASchwarzCMehnertWSolid lipid nanoparticles (SLN) for controlled drug delivery – drug release and release mechanismEur J Pharm Biopharm19984521491559704911
- VenkateswarluVManjunathKPreparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticlesJ Control Release200495362763815023472
- LvQYuAXiYDevelopment and evaluation of penciclovir-loaded solid lipid nanoparticles for topical deliveryInt J Pharm20093721–219119819429280
- CavalliRPeiraECaputoOGascoMRSolid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrinsInt J Pharm19991821596910332075
- JiaoJPolyoxyethylated nonionic surfactants and their applications in topical ocular drug deliveryAdv Drug Deliv Rev200860151663167318845195
- KatragaddaSTalluriRSMitraAKModulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving peptide transporter-mediated influx across rabbit corneaJ Ocul Pharmacol Ther200622211012016722797